Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04498598 · ClinicalTrials.gov registry record · NA

Structural Modification In Supraglottic Airway Device

A NA study of Hypoxia and Hypoventilation, sponsored by The Cleveland Clinic.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04498598: Recruiting NA study of Hypoxia and Hypoventilation, sponsored by The Cleveland Clinic.

NCT04498598 is a NA study of Hypoxia and Hypoventilation that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 100 participants, below the 3,114-participant average among 39 other Hypoxia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04498598, a NA study of Hypoxia and Hypoventilation, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The proposed A/Z modification of a supraglottic airway (SGA) incorporates an opening in the SGA body that enables access to the endotracheal tube (ETT) through the body of the SGA without the need of using an exchange catheter, thus enabling an ETT to move in the body of the SGA and convert a supraglottic to endotracheal ventilation. In its original form an adaptor made from same material currently used in the endotracheal tubes can make ventilation through the proposed airway device possible in exactly the same manner of a conventional SGA currently used. This adapter also known as the R-piece can be replaced with an ETT. The modification also allows placement of SGA over an existing ETT to convert and endotracheal (ET) to supraglottic (SG) mode of ventilation without the need to use an exchange catheter.

Primary Outcome

An alteration and structural modification in the supraglottic airway device can improve safety of airway exchange in patient needing general anesthesia, this proof of concept should show if the modification has any affect on oxygenation and ventilation.

Interventions

  • DEVICE A/Z Supraglottic airway

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-09-30
Est. Completion 2026-02-24
Phase NA
The Cleveland Clinic

688 total trials

What NCT04498598 shows while recruiting

NCT04498598 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,114-participant average among 39 other Hypoxia trials with a reported enrollment target (97% lower).

The record links to 4 conditions, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which A/Z Supraglottic airway is the first listed.

NCT04498598 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04498598 about?

NCT04498598 is a clinical study titled "Structural Modification In Supraglottic Airway Device". The proposed A/Z modification of a supraglottic airway (SGA) incorporates an opening in the SGA body that enables access to the endotracheal tube (ETT) through the body of the SGA without the need of using an exchange catheter, thus enabling an ETT to move in the body of the SGA and convert a suprag...

What is the current status of trial NCT04498598?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2020-09-30. Estimated completion is 2026-02-24.

What conditions does trial NCT04498598 study?

This clinical trial studies the following conditions: Hypoxia, Hypoventilation, Ventilation Therapy; Complications, Airway Complication of Anesthesia.

What interventions are being tested in trial NCT04498598?

The interventions under investigation include: A/Z Supraglottic airway (DEVICE).

Who is sponsoring clinical trial NCT04498598?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04498598 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04498598's enrollment target sits among peer trials

100 11th of 39 higher than 29 of 39 other Hypoxia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04498598, the US trial registry maintained by the National Library of Medicine. NCT04498598 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.